Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations.

Pain

Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA School of Medicine, Case Western Reserve University, Cleveland, OH, USA California Pacific Medical Center Research Institute, San Francisco, CA, USA United States Food and Drug Administration, Silver Spring, MD, USA Purdue Pharma LP, Stamford, CT, USA University of Pennsylvania, Philadelphia, PA, USA Departments of Anesthesiology and Perioperative Medicine and Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada Analgesic Solutions, Natick, MA, USA Tufts University, Boston, MA, USA Departments of Biostatistics and Computational Biology and Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA Depomed, Newark, CA, USA Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA Departments of Anesthesiology and Neurology and Center for Human Experimental Therapeutics, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

Published: December 2013

The National Institutes of Health released the trial registry ClinicalTrials.gov in 2000 to increase public reporting and clinical trial transparency. This systematic review examined whether registered primary outcome specifications (POS; ie, definitions, timing, and analytic plans) in analgesic treatment trials correspond with published POS. Trials with accompanying publications (n = 87) were selected from the Repository of Registered Analgesic Clinical Trials (RReACT) database of all postherpetic neuralgia, diabetic peripheral neuropathy, and fibromyalgia clinical trials registered at ClinicalTrials.gov as of December 1, 2011. POS never matched precisely; discrepancies occurred in 79% of the registry-publication pairs (21% failed to register or publish primary outcomes [PO]). These percentages did not differ significantly between industry and non-industry-sponsored trials. Thirty percent of the trials contained unambiguous POS discrepancies (eg, omitting a registered PO from the publication, "demoting" a registered PO to a published secondary outcome), with a statistically significantly higher percentage of non-industry-sponsored than industry-sponsored trials containing unambiguous POS discrepancies. POS discrepancies due to ambiguous reporting included vaguely worded PO registration; or failing to report the timing of PO assessment, statistical analysis used for the PO, or method to address missing PO data. At best, POS discrepancies may be attributable to insufficient registry requirements, carelessness (eg, failing to report PO assessment timing), or difficulty uploading registry information. At worst, discrepancies could indicate investigator impropriety (eg, registering imprecise PO ["pain"], then publishing whichever pain assessment produced statistically significant results). Improvements in PO registration, as well as journal policies requiring consistency between registered and published PO descriptions, are needed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pain.2013.08.011DOI Listing

Publication Analysis

Top Keywords

pos discrepancies
16
registered published
12
primary outcome
8
outcome specifications
8
trials
8
systematic review
8
clinical trials
8
unambiguous pos
8
failing report
8
discrepancies
7

Similar Publications

Species relationships and speciation have traditionally been represented by phylogenetic trees, but not all evolutionary histories fit into bifurcating divergence models. Introgressive hybridization challenges this assumption by sometimes [or maybe often] leading to mitochondrial introgression, wherein one species' mitochondrial genome is entirely replaced by another's (mitochondrial capture). Such processes result in mitonuclear discrepancies, complicating species delimitation and phylogenetic inference.

View Article and Find Full Text PDF

Comparison between PCR-RFLP and sequencing techniques in the analysis of Paracoccidioides spp. biodiversity: limitations and insights into species and variant differentiation.

Mycopathologia

November 2024

Laboratório de Investigação Médica em Micologia (LIM53), Instituto de Medicina Tropical de São Paulo, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Éneas de Carvalho Aguiar n470, Cerqueira Cézar, São Paulo, SP, 05403000, Brazil.

Background: The study of Paracoccidioides spp. faces significant challenges due to limitations inherent in the molecular biology techniques employed. Recently, new species were described whose geographical and genetic distributions were investigated.

View Article and Find Full Text PDF

Boldenone (BOL) has been frequently detected in doping and food safety over the past few decades. Researchers have studied BOL metabolism across various species, reporting significant differences even within the same species due to variations in experimental designs and analytical methods. Additionally, detection methods face challenges such as matrix interferences and the presence of endogenous structural analogs at low concentrations.

View Article and Find Full Text PDF
Article Synopsis
  • Platypnea orthodeoxia syndrome (POS) is a rare cause of low oxygen levels that requires careful clinical evaluation and collaboration among specialists for diagnosis.
  • An 86-year-old male presented to the ER with low oxygen saturation (84%) and did not improve with supplemental oxygen; however, his oxygen levels increased significantly when lying down.
  • Diagnosis was confirmed through echocardiography revealing a large patent foramen ovale (PFO) causing a right-to-left shunt; he was treated successfully, improving his oxygen levels and allowing him to go home without supplemental oxygen.*
View Article and Find Full Text PDF
Article Synopsis
  • A study in Pará, Northern Brazil, identified a unique strain of multidrug-resistant tuberculosis (MDR-TB) called SIT2517/T1, with a focus on its transmission dynamics.
  • Researchers utilized various genetic testing methods, including whole-genome sequencing, to analyze 28 isolates, confirming their distinct sublineage and highlighting discrepancies in drug resistance testing for some antibiotics.
  • The findings indicated a high probability of direct transmission among these isolates in urban areas, emphasizing the necessity for increased tuberculosis genomic surveillance in the Brazilian Amazon.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!